Loralie Langman, Ph.D., named to Clinical and Laboratory Standards Institute board of directors

Loralie Langman, Ph.D. (CBCH ’05), Division of Clinical Biochemistry at Mayo Clinic in Rochester, was named to the 2021 Clinical and Laboratory Standards Institute (CLSI) board of directors. Dr. Langman is a director of Mayo Clinic’s Clinical and Forensic Toxicology Laboratory and Clinical Mass Spectroscopy Laboratory. She also is a consultant in Mayo’s Personalized Genomics Laboratory and a professor of laboratory medicine and pathology.

A fellow with the Canadian Academy of Clinical Biochemistry, Dr. Langman is the first individual to have achieved diplomat status with the American Board of Clinical Chemistry in all three disciplines (clinical chemistry, molecular diagnostics, and toxicological chemistry). She also is a fellow with the American Board of Forensic Toxicology.